Loading…
← CockpitCompetitor Analysis › 002734.SZ Limin Group Co., Ltd. Class AOpen in the cockpit ↗

Limin Group Co., Ltd. Class A002734.SZCompetitor analysis, valuation and peers

China · CNY·Materials›Chemicals: Agricultural

Chinese pesticide manufacturer producing insecticides and other crop-protection chemicals.

Momentum laggard 6
Mkt cap
$692M
US dollars, full cap
Free float
62%
of shares outstanding
$/day
$31.4M
20-day average traded
Fwd P/E
7.9×
forward earnings
ROIC−WACC
+2.3 pp
WACC 7.4%
Hurdle
-4 pp
Req g minus delivered
Next earnings
149 days
16 Apr 2027
Close · CNYCN¥9.85
1D-2.4%
1W-13.5%
1M-28.2%
3M-36.2%
6M-42.2%
YTD-38.2%
1Y-45.5%
ATR %7.0%
52w lowhigh56.8% off high

What Limin does

Chinese pesticide manufacturer producing insecticides and other crop-protection chemicals.

Products and services

  • Insecticides
  • Other crop-protection chemicals

Customers

  • Agrochemical distributors
  • Export markets

Where it sits in the supply chain

  • Materials
  • Agricultural chemicals
  • Pesticides

What could go right

  • Crop-protection demand

What could go wrong

  • Pesticide price competition

Moat: none. Commodity pesticide producer in a fragmented, price-competitive domestic market.

Headquarters: Hebei, China · Employees: 4,593

Named competitors

Limin at a glance

Size Limin (002734.SZ) is a China Materials company (Chemicals: Agricultural) with a market value of $692M, the 2918th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥9.85 on 18 Nov 2026.

Performance Over six months the shares fell 42.2%, against -19.8% for the median peer and -20.0% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.

Growth Revenue fell 6.5% over the last twelve months (peer median +9.5%); the operating margin is 8.4% (peer median 3.3%).

Valuation It trades at 7.9× forward earnings against a peer median of 12.2× (2nd cheapest of 10).

Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -4 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 2.3 points above its cost of capital (7.4% WACC).

Next results Next results expected around 16 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010012021 May 202621 Aug 202618 Nov 2026Peer median 81002734.SZ 57
Six months, rebased to 100: Limin against the median of its 20 peers (local-currency closes).

Limin financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥4.19BCN¥4.52BCN¥4.24BCN¥4.19BCN¥5.01B
Revenue growth—+7%+1%-16%—
Gross profitCN¥1.26BCN¥1.10BCN¥729MCN¥609MCN¥865M
EBITDAn/aCN¥915MCN¥509MCN¥471MCN¥530M
Net incomeCN¥306MCN¥480MCN¥81.4MCN¥62.1MCN¥219M
Free cash flowCN¥426MCN¥465MCN¥269MCN¥229M-CN¥66.3M
Capital expenditureCN¥73.9MCN¥86.9MCN¥98.0MCN¥237MCN¥735M
Total debtCN¥1.87BCN¥1.62BCN¥3.00BCN¥2.98BCN¥2.76B

Quarterly statements and history in the cockpit →

Limin competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%-10%0%LXU603395002749FMC002538300505600227002470000713RCFKRISHANANUFGSFC0005256002286003896033344997002734.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Limin is the large dot.

Fundamentals: revenue growth against valuation

-20%0%+20%+40%20×40×LXU002749FMC300505000713NUFGSFC002556600389002734.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Limin is the large dot.

Capital: growth delivered against growth the price implies

-10%0%+10%+20%0%20%LXU002749FMC600227000713NUF600796GSFC0005250025566002284997002734.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Limin is the large dot.

Limin competitors and peer comparison

Head to head with its named competitors (002734.SZ vs 600486.SS vs 002215.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Limin 002734.SZ$692M-42%-6%8%7.9×-3.0%
Jiangsu Yangnong Chemical 600486.SS$3.24B-18%+3%13%15.4×0.0%
Shenzhen Noposion Crop Science 002215.SZ$1.03B-32%+12%13%7.7×-6.2%

How Limin compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Limin against its 20 peers (data as of 18 Nov 2026)
Measure002734.SZPeer medianRank in peer set
1-month return-28.2%-6.7%lowest of 21
6-month return-42.2%-19.8%4th lowest of 21
Distance from 52-week high-56.8%-39.2%5th lowest of 21
Revenue growth (TTM)-6.5%+9.5%2nd lowest of 21
Operating margin8.4%3.3%7th highest of 21
Forward P/E7.9×12.2×2nd cheapest of 10
Growth the price implies (Req g, 7 yrs)-3.0%4.6%4th least demanding of 13
Growth delivered (Del g)+0.6%+2.8%5th lowest of 13
Hurdle (Req g minus delivered)-3.7 pp+3.4 pp5th least demanding of 13
ROIC minus cost of capital+2.3 pp-2.1 pp4th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Limin 002734.SZChina$692M-42%-6%8%7.9×-3.0%+0.6%
LSB Industries LXUUnited States$689M-28%+13%11%9.9×-1.4%+11.9%
CNSIG Anhui Hongsifang Fertilizer 603395.SSChina$702M-29%+3%0%n/an/an/a
Sichuan Guoguang Agrochemical 002749.SZChina$660M-20%-2%18%13.2×-8.5%+12.2%
FMC FMCUnited States$728M-63%-22%-21%5.6×-3.0%-5.7%
Anhui Sierte Fertilizer Industry 002538.SZChina$747M-11%+9%3%n/an/an/a
Kunming Chuan Jin Nuo Chemical 300505.SZChina$758M-37%+14%10%8.3×n/an/a
Guizhou Chitianhua 600227.SSChina$762M-17%+16%-1%n/a16.3%+2.4%
Kingenta Ecological Engineering 002470.SZChina$775M-42%+9%-5%n/an/an/a
Sdic Fengle Seed 000713.SZChina$618M-16%+10%2%43.0×10.6%+3.4%
Rashtriya Chemicals & Fertilizers RCF.NSIndia$614M-16%+9%4%n/an/an/a
Krishana Phoschem KRISHANA.NSIndia$783M+77%+73%11%n/an/an/a
Nufarm NUF.AXAustralia$790M+31%-2%3%17.6×9.0%+5.2%
Zhejiang Qianjiang Biochemical 600796.SSChina$601M-20%-3%11%n/a0.9%-2.0%
Gujarat State Fertilizers & Chemicals GSFC.NSIndia$596M-21%+37%3%12.2×23.4%+3.2%
Nanjing Redsun 000525.SZChina$811M-17%+12%-2%n/a9.7%-5.1%
Anhui Huilong Agricultural Means of Production .Co 002556.SZChina$572M-25%0%1%18.3×8.4%-1.2%
Jiangxi Fanli Digital Technology 600228.SSChina$529M+45%+89%-7%n/a-13.5%+2.0%
Nantong Jiangshan Agrochemical & Chemicals 600389.SSChina$921M-45%+13%6%9.3×n/an/a
Suzhou Fengbei Biotech Stock 603334.SSChina$517M-48%+63%4%n/an/an/a
Nihon Nohyaku 4997.TJapan$509M+7%+5%11%n/a-8.8%+9.3%

Questions

Who are Limin's main competitors?
Named competitors: Jiangsu Yangnong Chemical (600486.SS), Shenzhen Noposion Crop Science (002215.SZ). The cockpit's measured peer set (industry) also includes LSB Industries (LXU), CNSIG Anhui Hongsifang Fertilizer (603395.SS), Sichuan Guoguang Agrochemical (002749.SZ), FMC (FMC), Anhui Sierte Fertilizer Industry (002538.SZ), Kunming Chuan Jin Nuo Chemical (300505.SZ).
Is Limin expensive compared with its peers?
On forward p/e it trades at 7.9× against a peer median of 12.2×, 2nd cheapest of 10 in its peer set. For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is +1%, so the hurdle is -4 pp: the price already allows for a slowdown.
How has Limin stock performed?
Over six months to 18 Nov 2026 the shares returned -42.2% against -19.8% for the median peer; over one year -45.5%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.